A staged approach to achieving clinical data intelligence – Marketscreener.com

A staged approach to achieving clinical data intelligence – Marketscreener.com

Sales 2022 3 439 M

Net income 2022 522 M

Net Debt 2022 1 369 M

P/E ratio 2022 28,1x
Yield 2022 1,75%
Capitalization 13 609 M
13 609 M
EV / Sales 2022 4,35x
EV / Sales 2023 4,03x
Nbr of Employees 14 300
Free-Float 97,8%

Chart OPEN TEXT CORPORATION

Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.


Period : DayWeek

Technical analysis trends OPEN TEXT CORPORATION

Short Term Mid-Term Long Term
Trends Neutral Neutral Neutral

Income Statement Evolution

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell

Buy

Mean consensus BUY
Number of Analysts 10
Last Close Price
50,37 $
Average target price
59,50 $
Spread / Average Target 18,1%

Please enable JavaScript in your browser’s settings to use dynamic charts.

Source: https://www.marketscreener.com/quote/stock/OPEN-TEXT-CORPORATION-10374/news/A-staged-approach-to-achieving-clinical-data-intelligence-36876029/